{"id":"W3171413004","doi":"10.1200/jco.2021.39.15_suppl.7523","title":"Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ibrutinib; Chlorambucil; Medicine; Hazard ratio; Chronic lymphocytic leukemia; IGHV@; Internal medicine; Oncology; Neutropenia; Progression-free survival; Confidence interval; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002786774,0.0001708118,0.001813518,0.0001832725,0.00003027264,0.000006280618,0.0003403172,0.0002478517,0.00005138696],"category_scores_gemma":[0.005384056,0.0001021895,0.0003991086,0.0004830061,0.0001583844,0.00005292731,0.0001037659,0.0003937106,0.000004474926],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02692584,"about_ca_system_score_gemma":0.05945606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005270999,"about_ca_topic_score_gemma":0.003401738,"domain_scores_codex":[0.9953807,0.0005620228,0.002513677,0.0002919358,0.0008833635,0.0003682803],"domain_scores_gemma":[0.9910225,0.006126952,0.001116686,0.0005120238,0.0009731649,0.0002487333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1875893,0.02961337,0.2791725,0.0009505561,0.005653917,0.006194967,0.02096783,0.007845699,0.0001198924,0.0001007349,0.00798601,0.4538052],"study_design_scores_gemma":[0.4867381,0.2768383,0.1936803,0.0007048775,0.001227848,0.0003161627,0.003314709,0.002399266,0.0003225007,0.0001049785,0.03413731,0.0002155247],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969561,0.0002892175,0.00002349976,0.0007200447,0.0005117836,0.001328967,0.00001270875,0.000003203342,0.0001544603],"genre_scores_gemma":[0.9980506,0.0002817196,0.0005187102,0.0002681954,0.0003517782,0.00004055173,0.000007752737,0.000026124,0.0004545625],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4535897,"threshold_uncertainty_score":0.9768096,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1174128857134083,"score_gpt":0.4522031796915162,"score_spread":0.334790293978108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}